(Bio)nanocomposites have been studied for biomedical applications, including the treatment of wounds. However, wound infection is one of the main problems of wound care management, and the use of wound dressings with antibacterial agents is essential. This work focused on developing and characterizing silver sulfadiazine-loaded halloysite/cassava starch-based (bio)nanocomposites potentially suitable as antimicrobial dressing. Silver sulfadiazine was complexed inside the halloysite nanotubes lumen, and the drug-loaded nanotubes were incorporated in thermoplastic starch dispersion, forming the (bio)nanocomposites. The silver sulfadiazine-loaded halloysite and the (bio)nanocomposite were characterized by zeta potential, scanning electron microscopy, X-ray diffraction, and infrared spectroscopy. The dressing properties of (bio)nanocomposites (water vapor permeability and mechanical stability) and their antimicrobial efficacy by Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were also evaluated. Physicochemical studies suggested the silver sulfadiazine-loaded halloysite complexation (zeta potential of −38.9 mV) and its interactions with the starch forming the nanocomposites. The silver sulfadiazine-loaded halloysite/starch-based (bio)nanocomposites possessed a homogeneous and organized structure. Also, they had mechanical properties to be used as a dressing (13.73 ± 3.09 MPa and 3.17 ± 1.28% of elongation at break), and its permeability (6.18 ± 0.43 (10−13) g.Pa−1.s−1.m−1) could be able to maintain the environmental moisture at the wound surface. Besides that, the (bio)nanocomposites acted against the studied bacteria, being a potential contact antimicrobial and biodegradable wound dressing. Finally, the developed (bio)nanocomposites are semi-occlusive and good candidates for dry wounds to be widely in vitro and in vivo tested as controlled silver sulfadiazine delivery dressing.
Ruiz-HitzkyEFernandesFM.Progress in bionanocomposites: from green plastics to biomedical applications. Prog Polym Sci2013;
38: 1391.
2.
DarderMArandaPRuiz-HitzkyE.Bionanocomposites: a new concept of ecological, bioinspired, and functional hybrid materials. Adv Mater2007;
19: 1309–1319.
3.
SessiniVRaquezJMKennyJM, et al.
Melt-processing of bionanocomposites based on ethylene-co-vinyl acetate and starch nanocrystals. Carbohydr Polym2019;
208: 382–390.
4.
OjijoVSinha RayS.Processing strategies in bionanocomposites. Prog Polym Sci2013;
38: 1543–1589.
5.
AvérousL.Biodegradable multiphase systems based on plasticized starch: a review. J Macromol Sci – Polym Rev2004;
44: 231–274.
6.
WuWCHsiaoPYHuangYC.Effects of amylose content on starch-chitosan composite film and its application as a wound dressing. J Polym Res2019;
26: 137.
7.
LiuMHeRYangJ, et al.
Polysaccharide-halloysite nanotube composites for biomedical applications: a review. Clay Miner2016;
51: 457–467.
8.
ChivracFPolletEAvérousL.Progress in nano-biocomposites based on polysaccharides and nanoclays. Mater Sci Eng R Reports2009;
67: 1–17.
9.
XieFPolletEHalleyPJ, et al.
Starch-based nano-biocomposites. Prog Polym Sci2013;
38: 1590–1628.
10.
ViserasCAguzziCCerezoP, et al.
Biopolymer-clay nanocomposites for controlled drug delivery. Mater Sci Technol2008;
24: 1020–1026.
11.
GeorgeAShahPAShrivastavPS.Natural biodegradable polymers based nano-formulations for drug delivery: a review. Int J Pharm2019;
561: 244–264.
12.
AthiraGKJyothiAN.Cassava starch-poly(vinyl alcohol) nanocomposites for the controlled delivery of curcumin in cancer prevention and treatment. Starch/Stärke2015;
67: 549–558.
13.
JesusDRBarbosaLNPrandoTBL, et al.
Ninety-day oral toxicity assessment of an alternative biopolymer for controlled release drug delivery systems obtained from cassava starch acetate. Evidence-Based Complement Altern Med2015;
2015: 1–7.
14.
NambisanB.Strategies for elimination of cyanogens from cassava for reducing toxicity and improving food safety. Food Chem Toxicol2011;
49: 690–693.
15.
OlivatoJBMariniJYamashitaF, et al.
Sepiolite as a promising nanoclay for nano-biocomposites based on starch and biodegradable polyester. Mater Sci Eng C2017;
70: 296–302.
16.
TorresFGCommeauxSTroncosoOP.Starch-based biomaterials for wound-dressing applications. Starch/Stärke2013;
65: 543–551.
17.
MurugesanSScheibelT.Copolymer/clay nanocomposites for biomedical applications. Adv Funct Mater2020;
30: 1908101–190.
18.
HanifMJabbarFSharifS, et al.
Halloysite nanotubes as a new drug-delivery system: a review. Clay Miner2016;
51: 469–477.
19.
PandeyGMunguambeDMTharmavaramM, et al.
Halloysite nanotubes - an efficient 'nano-support' for the immobilization of α-amylase. Appl Clay Sci2017;
136: 184–191.
20.
WuYZhangYJuJ, et al.
Advances in halloysite nanotubes-polysaccharide nanocomposite preparation and applications. Polymers (Basel)2019;
11: 987.
21.
LiuMJiaZJiaD, et al.
Recent advance in research on halloysite nanotubes-polymer nanocomposite. Prog Polym Sci2014;
39: 1498–1525.
22.
YuanPTanDAnnabi-BergayaF.Properties and applications of halloysite nanotubes: recent research advances and future prospects. Appl Clay Sci2015;
112–113: 75–93.
23.
LvovYAbdullayevE.Functional polymer-clay nanotube composites with sustained release of chemical agents. Prog Polym Sci2013;
38: 1690–1719.
24.
CavallaroGDanilushkinaAAEvtugynVG, et al.
Halloysite nanotubes: controlled access and release by smart gates. Nanomaterials2017;
7: 199–112.
25.
LevisSRDeasyPB.Characterisation of halloysite for use as a microtubular drug delivery system. Int J Pharm2002;
243: 125–134.
26.
LvovYMDeVilliersMMFakhrullinRF.The application of halloysite tubule nanoclay in drug delivery. Expert Opin Drug Deliv2016;
13: 977–986.
27.
AbdullayevELvovY.Halloysite for controllable loading and release. In: Yuan PThill ABergaya F (eds) Nanosized tubular clay minerals; vol. 7.
New York:
Elsevier, pp. 554–605.
28.
FerrariPCAraujoFFPianaroSA.Halloysite nanotubes-polymeric nanocomposites: characteristics, modifications and controlled drug delivery approaches. Cerâmica2017;
63: 423–431.
29.
PanHFanDDuanZ, et al.
Non-stick hemostasis hydrogels as dressings with bacterial barrier activity for cutaneous wound healing. Mater Sci Eng C2019;
105: 110118.
30.
StavitskayaABatashevaSVinokurovV, et al.
Antimicrobial applications of clay nanotube-based composites. Nanomaterials2019;
9: 708–720.
31.
LeeYMKimSSParkMH, et al.
β-Chitin-based wound dressing containing silver sulfurdiazine. J Mater Sci Mater Med2000;
11: 817–823.
32.
AtiyehBSCostagliolaMHayekSN, et al.
Effect of silver on burn wound infection control and healing: review of the literature. Burns2007;
33: 139–148.
33.
AbdullahZWDongYHanN, et al.
Water and gas barrier properties of polyvinyl alcohol (PVA)/starch (ST)/glycerol (GL)/halloysite nanotube (HNT) bionanocomposite films: experimental characterisation and modelling approach. Compos Part B: Eng2019;
174: 107033.
34.
NejaddehbashiFHashemitabarMBayatiV, et al.
Incorporation of silver sulfadiazine into an electrospun composite of polycaprolactone as an antibacterial scaffold for wound healing in rats. Cell J2020;
21: 379–390.
35.
VincenzoBRiccioFKlosowskiAB, et al.
Chitosan/nanocellulose-based bionanocomposite films for controlled betamethasone and silver sulfadiazine delivery. J Appl Polym Sci2021.
36.
American Society for Testing and Materials.Standard test method for tensile properties of thin plastic sheeting.
West Conshohocken, PA:
ASTM, 2002.
37.
ASTM E 96.Standard test methods for water vapor transmission of materials.
West Conshohocken, PA:
ASTM, 1995.
38.
LemesBMNovatskiAFerrariPC, et al.
Physicochemical, biological and release studies of chitosan membranes incorporated with Euphorbia umbellata fraction. Brazilian J Pharmacogn2018;
28: 433–443.
39.
ZahaDCBungauSAleyaS, et al.
What antibiotics for what pathogens? The sensitivity spectrum of isolated strains in an intensive care unit. Sci Total Environ2019;
687: 118–127.
40.
AbdullahZWDongY.Preparation and characterisation of poly(vinyl) alcohol (PVA)/starch (ST)/halloysite nanotube (HNT) nanocomposite films as renewable materials. J Mater Sci2018;
53: 3455–3469.
41.
WangQZhangJWangA.Spray-dried magnetic chitosan/Fe3O4/halloysite nanotubes/ofloxacin microspheres for sustained release of ofloxacin. RSC Adv2013;
3: 23423–23431.
42.
OliyaeiNMoosavi-NasabMTamaddonAM, et al.
Encapsulation of fucoxanthin in binary matrices of porous starch and halloysite. Food Hydrocoll2020;
100: 105458.
43.
HarikrishnanSSedevRBehCC, et al.
Loading of 5-fluorouracil onto halloysite nanotubes for targeted drug delivery using a subcritical gas antisolvent process (GAS). J Supercrit Fluids2020;
159: 104756.
44.
CaoZSunXYaoJ, et al.
Silver sulfadiazine-immobilized celluloses as biocompatible polymeric biocides. J Bioact Compat Polym2013;
28: 398–410.
45.
SchmittHPrashanthaKSoulestinJ, et al.
Preparation and properties of novel melt-blended halloysite nanotubes/wheat starch nanocomposites. Carbohydr Polym2012;
89: 920–927.
46.
XieYChangPRWangS, et al.
Preparation and properties of halloysite nanotubes/plasticized Dioscorea opposita Thunb. starch composites. Carbohydr Polym2011;
83: 186–191.
47.
BarkatMAHarshita AhmadI, et al.
Nanosuspension-based aloe vera gel of silver sulfadiazine with improved wound healing activity. AAPS PharmSciTech2017;
18: 3274–3285.
48.
Yassue-CordeiroPHZandonaiHGenesiBP.Development of chitosan/silver sulfadiazine/zeolite composite films for wound dressing. Pharmaceutics2019;
11: 535.
49.
BulbulYEOkurMDemirtas-KorkmazF, et al.
Development of PCL/PEO electrospun fibrous membranes blended with silane-modified halloysite nanotube as a curcumin release system. Appl Clay Sci2020;
186: 105430.
50.
PsimadasDGeorgouliasPValotassiouV, et al.
Molecular nanomedicine towards cancer. J Pharm Sci2012;
101: 2271–2280.
51.
Naseri-NosarMZioraZM.Wound dressings from naturally-occurring polymers: a review on homopolysaccharide-based composites. Carbohydr Polym2018;
189: 379–398.
52.
ShiRNiuYGongM, et al.
Antimicrobial gelatin-based elastomer nanocomposite membrane loaded with ciprofloxacin and polymyxin B sulfate in halloysite nanotubes for wound dressing. Mater Sci Eng C2018;
87: 128–138.
53.
KurczewskaJPecynaPRatajczakM, et al.
Halloysite nanotubes as carriers of vancomycin in alginate-based wound dressing. Saudi Pharm J2017;
25: 911–920.
54.
TenciMRossiSAguzziC, et al.
Carvacrol/clay hybrids loaded into in situ gelling films. Int J Pharm2017;
531: 676–688.
55.
GorrasiG.Dispersion of halloysite loaded with natural antimicrobials into pectins: characterization and controlled release analysis. Carbohydr Polym2015;
127: 47–53.
56.
RenJHanLCaiH, et al.
Functional biocomposites based on plasticized starch/halloysite nanotubes for drug-release applications. Starch - Stärke2018;
70: 1700358.
57.
LisuzzoLWickleinBLo DicoG, et al.
Functional biohybrid materials based on halloysite, sepiolite and cellulose nanofibers for health applications. Dalton Trans2020;
49: 3830–3840.
58.
BarmanMMahmoodSAugustineR, et al.
Natural halloysite nanotubes/chitosan based bio-nanocomposite for delivering norfloxacin, an anti-microbial agent in sustained release manner. Int J Biol Macromol2020;
162: 1849–1861.
59.
SaadatSPandeyGTharmavaramM, et al.
Nano-interfacial decoration of halloysite nanotubes for the development of antimicrobial nanocomposites. Adv Colloid Interface Sci2020;
275: 102063.
60.
MalakinezhadHKalaeeMAbdoussM, et al.
Fabrication and characterization of biodegradable pH-Responsive halloysite poly(lactic-co-glycolic acid) micro-sphere for controlled released of phenytoin sodium. J Inorg Organomet Polym Mater2020;
30: 722–730.
MeiraSMMZehetmeyerGWernerJO, et al.
A novel active packaging material based on starch-halloysite nanocomposites incorporating antimicrobial peptides. Food Hydrocoll2017;
63: 561–570.
63.
FrostKKaminskiDKirwanG, et al.
Crystallinity and structure of starch using wide angle X-ray scattering. Carbohydr Polym2009;
78: 543–548.
64.
OlivatoJBMariniJPolletE, et al.
Elaboration, morphology and properties of starch/polyester nano-biocomposites based on sepiolite clay. Carbohydr Polym2015;
118: 250–256.
65.
MaliSGrossmannMVEGarciaMA, et al.
Microstructural characterization of yam starch films. Carbohydr Polym2002;
50: 379–386.
66.
MariniJBretasRES.Halloysite nanotubes as reinforcing fillers in polymeric nanocomposites. Soc Plast Eng - Plast Res Online2013;
1: 1–3.
67.
DeviNDuttaJ.Development and in vitro characterization of chitosan/starch/halloysite nanotubes ternary nanocomposite films. Int J Biol Macromol2019;
127: 222–231.
68.
ZhangYChweeTLRamakrishnaS, et al.
Recent development of polymer nanofibers for biomedical and biotechnological applications. J Mater Sci Mater Med2005;
16: 933–946.
MoeiniAPedramPMakvandiP, et al.
Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: a review. Carbohydr Polym2020;
233: 115839.
71.
AlvesVDMaliSBeléiaA, et al.
Effect of glycerol and amylose enrichment on cassava starch film properties. J Food Eng2007;
78: 941–946.
72.
PowersJGMortonLMPhillipsTJ.Dressings for chronic wounds. Dermatol Ther2013;
26: 197–206.
73.
MorgadoPIAguiar-RicardoACorreiaIJ.Asymmetric membranes as ideal wound dressings: an overview on production methods, structure, properties and performance relationship. J Memb Sci2015;
490: 139–151.
74.
ChangPRJianRYuJ, et al.
Fabrication and characterisation of chitosan nanoparticles/plasticised-starch composites. Food Chem2010;
120: 736–740.
75.
SunerSSSahinerMAkcaliA, et al.
Functionalization of halloysite nanotubes with polyethyleneimine and various ionic liquid forms with antimicrobial activity. J Appl Polym Sci2020;
137: 48352.
76.
NalbandiBAmiriS.Antibacterial activity of PVA-based nanofibers loaded with silver sulfadiazine/cyclodextrin nanocapsules. Int J Polym Mater Polym Biomater2019;
68: 647–659.
77.
LuoTShakyaSMittalP, et al.
Co-delivery of superfine nano-silver and solubilized sulfadiazine for enhanced antibacterial functions. Int J Pharm2020;
584: 119407.
78.
Bakhsheshi-RadHRChenXIsmailAF, et al.
Improved antibacterial properties of an Mg-Zn-Ca alloy coated with chitosan nanofibers incorporating silver sulfadiazine multiwall carbon nanotubes for bone implants. Polym Adv Technol2019;
30: 1333–1339.
